Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
1.640
+0.240 (17.14%)
Nov 21, 2024, 11:07 AM EST - Market open
Intelligent Bio Solutions Ratios and Metrics
Market cap in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Nov '24 Nov 21, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
Market Capitalization | 7 | 6 | 6 | 10 | 49 | - | |
Market Cap Growth | 206.47% | -7.57% | -34.31% | -79.80% | - | - | |
Enterprise Value | 3 | -3 | 6 | -1 | 34 | - | |
Last Close Price | 1.40 | 1.92 | 33.36 | 158.88 | 945.60 | - | |
PS Ratio | 1.10 | 1.92 | 5.15 | - | 24.63 | - | |
PB Ratio | 1.00 | 0.73 | 1.76 | 1.51 | 3.25 | - | |
P/TBV Ratio | 4.31 | 1.51 | - | 1.49 | 3.24 | - | |
EV/Sales Ratio | 0.82 | - | 4.54 | - | 17.42 | - | |
Debt / Equity Ratio | 0.14 | 0.11 | 0.36 | - | - | -0.98 | |
Asset Turnover | 0.31 | 0.26 | 0.11 | - | 0.16 | 0.08 | |
Inventory Turnover | 1.93 | 1.92 | - | - | - | - | |
Quick Ratio | 0.92 | 1.36 | 0.42 | 2.20 | 4.29 | 0.06 | |
Current Ratio | 1.14 | 1.57 | 0.66 | 2.33 | 4.94 | 0.30 | |
Return on Equity (ROE) | -290.94% | -171.71% | -208.44% | -77.34% | -144.21% | - | |
Return on Assets (ROA) | -64.15% | -53.26% | -46.44% | -30.46% | -26.78% | -67.72% | |
Return on Capital (ROIC) | -143.13% | -91.31% | -91.16% | -48.35% | -43.67% | -303.17% | |
Earnings Yield | -175.09% | -169.72% | -164.21% | -84.26% | -14.42% | - | |
FCF Yield | -182.68% | -163.64% | -121.74% | -37.92% | -23.16% | - | |
Buyback Yield / Dilution | -2038.60% | -1802.54% | -37.01% | -40.81% | -22.38% | -1.52% | |
Total Shareholder Return | -2038.60% | -1802.54% | -37.01% | -40.81% | -22.38% | -1.52% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.